Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-12-15

Clinical Trial Update: Study of LX3305 in Subjects With Active Rheumatoid Arthritis on Stable Methotrexate [Phase 2]

View source ↗

Summary

Phase 2 study of LX3305 in patients with active rheumatoid arthritis on stable methotrexate has completed and results were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LX3305

Snippet

Sponsor: Lexicon Pharmaceuticals | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED | Results posted: 2011-12-15